Submit Manuscript

E-Pub Full Text Articles

The Endocrine Disruptor Bisphenol A (BPA) Exerts a Wide Range of Effects in Carcinogenesis and Response to Therapy

Author(s): Shirin A. Hafezi and Wael M. Abdel-Rahman*
Pages: 1-9 (9)
Mesalazine Activates Adenosine Monophosphate-activated Protein Kinase: Implication in the Anti-inflammatory Activity of this Anti-colitic Drug

Author(s): Heejung Park, Wooseong Kim, Dayoon Kim, Seongkeun Jeong and Yunjin Jung*
Pages: 1-9 (9)
Convergence of Canonical and Non-Canonical Wnt Signal: Differential Kat3 Coactivator Usage

Author(s): Keane K.Y. Lai*, Cu Nguyen, Kyung-Soon Lee, Albert Lee, David P. Lin, Jia-Ling Teo and Michael Kahn*
Pages: 1-17 (17)
Targeting Chromatin Remodeling for Cancer Therapy

Author(s): Jasmine Kaur, Abdelkader Daoud and Scott T. Eblen*
Pages: 1-15 (15)
New Insights in Cannabinoid Receptor Structure and Signaling

Author(s): Lingyan Ye, Zheng Cao, Weiwei Wang and Naiming Zhou*
Pages: 1-9 (9)
A Contemporary Overview of PPARα/γ Dual Agonists for the Management of Diabetic Dyslipidemia

Author(s): Pitchai Balakumar*, Nanjaian Mahadevan and Ramanathan Sambathkumar
Pages: 1-7 (7)
Mitochondria-Targeted Drugs

Author(s): Roman A. Zinovkin* and Andrey A. Zamyatnin*
Pages: 1-13 (13)
Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions

Author(s): Ricardo Jorge Dinis-Oliveira*, Carolina Lanca Pereira and Diana Dias da Silva
Pages: 1-11 (11)